Border Medical Oncology & Haematology

Border Medical Oncology & Haematology Research Unit has twice been awarded NSW Premier’s Award for innovation in Cancer Clinical Trials. In 2019 the unit was awarded $18.6 million to undertake critical cancer-related clinical trials in regional Victoria. The funding from the Australian Government’s Medical Research Future Fund (MRFF) will go to the Regional Victorian Trials Alliance, Linkages, Special populations, Equity (ReViTALISE) Program and will run over five years. The project involves eight Clinical Research Sites in Regional Victoria and partners with Metropolitan specialists and academics to deliver a number of projects specific to regional and rural health care needs.

See https://bordermedonc.com.au/

The not-for-profit Border Medical Oncology Research Unit was established in 1998, and to date this unit has been involved in over 350 clinical trials with over 2,000 patients recruited. Types of studies range from surveys to preventative studies to phase I, II and III trials for treatment for medical oncology and haematology, adjuvant and metastatic cancers.

HRICS works in partnership with health services and consumers to promote coordinated planning, system integration and improvement of cancer services across their respective regions.